ClinicalTrials.gg
Drug

Namilumab clinical trials

studies test it
6
open now
0
in phase 3
0
first study started
2011

How each study uses namilumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Namilumab
5

Development codes

MT203
1

Studies by the year they started

6 studies that test it; most in 2014 (2)

Studies that test namilumab, by start year
YearStudies
20111
20142
20181
20222

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 0

Takeda (3) · Kinevant Sciences GmbH (2) · Izana Bioscience Ltd. (1)

Studies

Open first, then newest update. How each study uses namilumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

As the comparator · 1 — what is tested is compared with namilumab

Codes

What other systems call namilumab · ClinicalTrials.gg INT000834

  • MeSH (NLM) C000624713namilumabOne source NLM
  • UNII (FDA) MED485W763NAMILUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q6961860namilumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97943NamilumabOne source FDA
  • DrugBank DB13037One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.